Methylguanine methyltransferase testing in glioblastoma: when and how?
| Data(s) |
2007
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_29DE24CD91A7 isbn:1527-7755[electronic] pmid:17442986 doi:10.1200/JCO.2006.09.7139 isiid:000245920300001 |
| Idioma(s) |
en |
| Fonte |
Journal of Clinical Oncology, vol. 25, no. 12, pp. 1459-1460 |
| Palavras-Chave | #Brain Neoplasms/diagnosis; Brain Neoplasms/drug therapy; Dacarbazine/analogs & derivatives; Dacarbazine/therapeutic use; Female; Glioblastoma/diagnosis; Glioblastoma/drug therapy; Humans; Male; Neoplasm Staging; O(6)-Methylguanine-DNA Methyltransferase/analysis; O(6)-Methylguanine-DNA Methyltransferase/metabolism; Prognosis; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tumor Markers, Biological/analysis; Tumor Markers, Biological/metabolism |
| Tipo |
info:eu-repo/semantics/article article |
